Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gustas Sasnauskas"'
Autor:
Gustas Sasnauskas, Aivaras Grybas
Publikováno v:
Lietuvos Chirurgija, Vol 20, Iss 2 (2021)
Background. Recurrent proximal ureteral stricture is a complex rare disease that is difficult to treat. Post-operative scarring, impaired blood supply to the ureter, stricture-related stones, and chronic infection – all factors make the treatment e
Externí odkaz:
https://doaj.org/article/29f9673efd6542058756d960caa8de6f
Autor:
Martynas Lukšta, Gustas Sasnauskas, Augustinas Baušys, Andrius Rybakovas, Justas Kuliavas, Rimantas Baušys, Kęstutis Strupas
Publikováno v:
Lietuvos Chirurgija, Vol 20, Iss 2 (2021)
Background. Gastric cancer remains one of the most common cancers in Lithuania and Worldwide. Surgical treatment is the only potentially curative treatment option for it. Historically open gastrectomy was considered as the gold standard approach. Alt
Externí odkaz:
https://doaj.org/article/650d45b882904bddb4648528278ffa4f
Autor:
Augustinas Bausys, Andrius Rybakovas, Gustas Sasnauskas, Rimantas Bausys, Martynas Luksta, Justas Kuliavas, Kęstutis Strupas
Publikováno v:
Lietuvos Chirurgija, Vol 20, Iss 2 (2021)
Background. Gastric cancer remains one of the most common cancers in Lithuania and Worldwide. Surgical treatment is the only potentially curative treatment option for it. Historically open gastrectomy was considered as the gold standard approach. Alt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::279d4f575e90652a7e6acf95315bd871
https://doi.org/10.15388/lietchirur.2021.20.43
https://doi.org/10.15388/lietchirur.2021.20.43
Publikováno v:
Cancers, Vol 13, Iss 2453, p 2453 (2021)
Cancers, Basel : MDPI, 2021, vol. 13, iss. 10, art. no. 2453, p. 1-13
Cancers
Volume 13
Issue 10
Cancers, Basel : MDPI, 2021, vol. 13, iss. 10, art. no. 2453, p. 1-13
Cancers
Volume 13
Issue 10
Objective: To assess the significance of prostate-specific antigen (PSA) persistence at the first measurement after radical prostatectomy (RP) on long-term outcomes in different prostate cancer risk groups. Methods: Persistent PSA was defined as ³0.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::257b6aab63a7827530327348e6e43534
https://www.mdpi.com/2072-6694/13/10/2453
https://www.mdpi.com/2072-6694/13/10/2453